SCHEMBL3908903

SCHEMBL3908903

CC1([N+](=O)[O-])CC=CC([N+](=O)[O-])=C1O

nearest known ligand 0.37

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 1/20 0.37
MEN1 O00255 1/20 0.32
LMNA P02545 1/20 0.32
HTT P42858 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27484242 0.72 MEN1 (0.32) MEN1LMNAHTTKMT2A
SCHEMBL11789455 0.71 AKR1B1 (0.36) AKR1B1
SCHEMBL27552581 0.71 NR3C1 (0.35) MEN1LMNAHTTKMT2A
SCHEMBL322124 0.64 MEN1 (0.33) MEN1LMNAHTTKMT2A
SCHEMBL27674634 0.62 ALDH1A1 (0.33) MEN1LMNAHTTKMT2A
SCHEMBL7010827 0.59 CA1 (0.31)
SCHEMBL15176880 0.59
SCHEMBL11651861 0.57
SCHEMBL28176113 0.57
SCHEMBL12281360 0.57 ACHE (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5028355-A Conductive polyurethane foam containing picric acid and analog thereof CREST-FOAM CORPORATION (US) 1991-07-02 US claimed
EP-0316446-A4 IMPROVED CONDUCTIVE POLYURETHANE FOAM COMPOSITIONS AND METHOD 1991-03-20 EP claimed
US-4982034-A ALKYLATION, OXIDATIVE DEHYDROGENATION, DISTILLATION, EVAPORATION, ADSORPTION AMOCO CORPORATION (US) 1991-01-01 US claimed
US-4973787-A USE OF DINITROCRESOL AS POLYMERIZATION INHIBITOR THE GOODYEAR TIRE & RUBBER COMPANY (US) 1990-11-27 US claimed
EP-0316446-A1 IMPROVED CONDUCTIVE POLYURETHANE FOAM COMPOSITIONS AND METHOD CREST-FOAM Corp. (US) 1989-05-24 EP claimed
WO-1988009350-A1 IMPROVED CONDUCTIVE POLYURETHANE FOAM COMPOSITIONS AND METHOD CREST-FOAM COPORATION (US) 1988-12-01 WO claimed
US-10138183-B2 Process and composition for inhibiting the polymerization of cyclopentadiene compounds EVONIK DEGUSSA GMBH (DE) 2018-11-27 US disclosed
US-9670116-B2 Process and composition for inhibiting the polymerization of cyclopentadiene compounds EVONIK DEGUSSA GMBH (DE) 2017-06-06 US disclosed
US-9493382-B2 Process and composition for inhibiting the polymerization of cyclopentadiene compounds EVONIK DEGUSSA GMBH (DE) 2016-11-15 US disclosed
US-20160237346-A1 PROCESS AND COMPOSITION FOR INHIBITING THE POLYMERIZATION OF CYCLOPENTADIENE COMPOUNDS EVONIK DEGUSSA GMBH (DE) 2016-08-18 US disclosed
US-20160237008-A1 PROCESS AND COMPOSITION FOR INHIBITING THE POLYMERIZATION OF CYCLOPENTADIENE COMPOUNDS EVONIK DEGUSSA GMBH (DE) 2016-08-18 US disclosed
US-20140288337-A1 PROCESS AND COMPOSITION FOR INHIBITING THE POLYMERIZATION OF CYCLOPENTADIENE COMPOUNDS EVONIK INDUSTRIES AG (DE) 2014-09-25 US disclosed
US-7585132-B2 Method for remediating a contaminated site Imbrie, James (US) 2009-09-08 US disclosed
US-5396004-A Diamine, hydroxylamine BETZ LABORATORIES, INC. (US) 1995-03-07 US disclosed
US-5028355-A Conductive polyurethane foam containing picric acid and analog thereof CREST-FOAM CORPORATION (US) 1991-07-02 US disclosed
EP-0316446-A4 IMPROVED CONDUCTIVE POLYURETHANE FOAM COMPOSITIONS AND METHOD 1991-03-20 EP disclosed
US-4982034-A ALKYLATION, OXIDATIVE DEHYDROGENATION, DISTILLATION, EVAPORATION, ADSORPTION AMOCO CORPORATION (US) 1991-01-01 US disclosed
US-4886626-A REDUCTION OF ELECTRICAL RESISTANCE CREST-FOAM CORPORATION (US) 1989-12-12 US disclosed
EP-0316446-A1 IMPROVED CONDUCTIVE POLYURETHANE FOAM COMPOSITIONS AND METHOD CREST-FOAM Corp. (US) 1989-05-24 EP disclosed
WO-1988009350-A1 IMPROVED CONDUCTIVE POLYURETHANE FOAM COMPOSITIONS AND METHOD CREST-FOAM COPORATION (US) 1988-12-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140288337-A1 PROCESS AND COMPOSITION FOR INHIBITING THE POLYMERIZATION OF CYCLOPENTADIENE COMPOUNDS CYC1, SQOR, UQCRB AKR1B1 1456/4885MEN1 1843/4885LMNA 2428/4885
US-20160237008-A1 PROCESS AND COMPOSITION FOR INHIBITING THE POLYMERIZATION OF CYCLOPENTADIENE COMPOUNDS CYC1, SQOR, UQCRB AKR1B1 1456/4885MEN1 1843/4885LMNA 2428/4885
US-10138183-B2 Process and composition for inhibiting the polymerization of cyclopentadiene compounds CYC1, SQOR, UQCRB AKR1B1 1456/4885MEN1 1843/4885LMNA 2428/4885
US-20160237346-A1 PROCESS AND COMPOSITION FOR INHIBITING THE POLYMERIZATION OF CYCLOPENTADIENE COMPOUNDS CYC1, SQOR, UQCRB AKR1B1 1456/4885MEN1 1843/4885LMNA 2428/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.